Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial

February 2021

Author(s): Mingrone G, van Baar AC, Deviere J, Hopkins D, Moura E, Cercato C, et al

Details: Gut. 2021

NIHR Acknowledged: Yes